These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2737099

  • 1. [Chronic interstitial nephritis after treatment with 5-aminosalicylic acid].
    Henning HV, Meinhold J, Eisenhauer T, Scheler F, Gröne HJ.
    Dtsch Med Wochenschr; 1989 Jul 07; 114(27):1091. PubMed ID: 2737099
    [No Abstract] [Full Text] [Related]

  • 2. [Acute interstitial nephritis caused by 5-aminosalicylic acid?].
    Ruf-Ballauf W, Hofstädter F, Krentz K.
    Internist (Berl); 1989 Apr 07; 30(4):262-4. PubMed ID: 2661466
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
    Smilde TJ, van Liebergen FJ, Koolen MI, Gerlag PG, Assmann KJ, Berden JH.
    Ned Tijdschr Geneeskd; 1994 Dec 17; 138(51):2557-61. PubMed ID: 7830805
    [Abstract] [Full Text] [Related]

  • 6. Mesalazine induced interstitial nephritis.
    Thuluvath PJ, Ninkovic M, Calam J, Anderson M.
    Gut; 1994 Oct 17; 35(10):1493-6. PubMed ID: 7959212
    [Abstract] [Full Text] [Related]

  • 7. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
    Niv Y.
    Isr J Med Sci; 1987 Nov 17; 23(11):1161-3. PubMed ID: 3436802
    [No Abstract] [Full Text] [Related]

  • 8. Interstitial nephritis associated with 5-aminosalicylic acid.
    Witte T, Olbricht CJ, Koch KM.
    Nephron; 1994 Nov 17; 67(4):481-2. PubMed ID: 7969684
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE, Kane S.
    Rev Gastroenterol Disord; 2004 Nov 17; 4(2):86-91. PubMed ID: 15185719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute interstitial nephritis due to mesalazine.
    Tadic M, Grgurevic I, Scukanec-Spoljar M, Bozic B, Marusic S, Horvatic I, Galesic K.
    Nephrology (Carlton); 2005 Apr 17; 10(2):103-5. PubMed ID: 15877665
    [Abstract] [Full Text] [Related]

  • 15. Mesalazine-associated interstitial nephritis: twice in the same patient.
    Manenti L, De Rosa A, Buzio C.
    Nephrol Dial Transplant; 1997 Sep 17; 12(9):2031. PubMed ID: 9306372
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Exanthema in 2 patients with ulcerative colitis treated with Pentasa].
    Grøn I, Winther A.
    Ugeskr Laeger; 1988 Jan 04; 150(1):32. PubMed ID: 2967564
    [No Abstract] [Full Text] [Related]

  • 18. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R, Hanson J, Safdi M, Wruble L, Hardi R, Johanson J, Koval G, Riff D, Winston B, Cross A, Doty P, Johnson LK.
    Am J Gastroenterol; 2002 Dec 04; 97(12):3078-86. PubMed ID: 12492193
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Severe tubulo-interstitial nephritis secondary to 5-ASA].
    Bosque López MJ, Garrido Durán C, Ginard Vicens D, Munar Vila MA, Vanrell Garau M, Mariño Méndez Z, Gayà Cantallops J.
    Gastroenterol Hepatol; 2009 Jan 04; 32(1):29-31. PubMed ID: 19174096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.